Novel and highly potent histamine H3 receptor ligands. Part 2: Exploring the cyclohexylamine-based series
Olivier Labeeuw, Nicolas Levoin, Olivia Poupardin et al. · Bioorganic & Medicinal Chemistry Letters · 2011
Cited by 9 works. doi:10.1016/j.bmcl.2011.06.102
Authors
- Olivier Labeeuw
- Nicolas Levoin
- Olivia Poupardin
- Thierry Calmels
- Xavier Ligneau
- Isabelle Berrebi‐Bertrand
- Philippe Robert
- Jeanne‐Marie Lecomte
- Jean-Charles Schwartz
- Marc Capet
References
- Auto-inhibition of brain histamine release mediated by a novel class (H3) of histamine receptor
- Group contributions to the thermodynamic properties of non-ionic organic solutes in dilute aqueous solution
- Cloning and Functional Expression of the Human Histamine H3Receptor
- Histamine inhibits dopamine release in the mouse striatum via presynaptic H3 receptors
- The histamine H3 receptor: from discovery to clinical trials with pitolisant
- S-[2-(4-imidazolyl)ethyl]isothiourea, a highly specific and potent histamine H3 receptor agonist.
- An inverse agonist of the histamine H3 receptor improves wakefulness in narcolepsy: Studies in orexin−/− mice and patients
- Inhibition of cortical acetylcholine release and cognitive performance by histamine H 3 receptor activation in rats
- The histamine H3receptor: an attractive target for the treatment of cognitive disorders
- BF2.649 [1-{3-[3-(4-Chlorophenyl)propoxy]propyl}piperidine, Hydrochloride], a Nonimidazole Inverse Agonist/Antagonist at the Human Histamine H3 Receptor: Preclinical Pharmacology